Medtronic (NYSE: MDT) today announced new data supporting its Aurora and OmniaSecure defibrillation technology offerings.
Background: Although more than 150,000 implantable cardioverter defibrillators (ICDs) are implanted yearly worldwide, only few studies systematically examined complications of ICD therapy in large ...
Please provide your email address to receive an email when new articles are posted on . Abbott announced that a cardiac resynchronization therapy defibrillator and an implantable cardioverter ...
A standard test of the implantable cardioverter defibrillator (ICD) is linked to significant thought-processing problems that improve for most patients within a year after the device is inserted, ...
Boston Scientific Shockless Implant Evaluation (SIMPLE) Study Results Presented at Heart Rhythm 2014, the Heart Rhythm Society's 35th Annual Scientific Sessions The trial results demonstrated that ...
A wearable automatic defibrillator may be an alternative to an implantable cardiac defibrillator for a small group of patients, say researchers. There are few large, randomized and controlled clinical ...
Ventricular fibrillation appears to be a newly identified diagnosis among Sen. John Fetterman’s ongoing medical issues, ...
ICD-related complications including inappropriate shocks were observed in total, in 136 of 440 study patients (31%) during 46 ± 37 months follow-up as summarized in Table II. Complications without ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback